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CHIECO-BIANCHI et al. (1963) reported that Swiss mice receiving urethane as a
subcutaneous injection at birth (1 mg./g. body weight) followed by twice weekly
applications of croton oil, starting at forty days, developed skin papillomas. The
tumour incidence was significantly greater than that in mice given urethane or
croton oil only, and that in mice given an equivalent dose (on a body weight basis)
of urethane at forty days and similar treatment with croton oil.
Graffi, Scharsach and Heyer (1955) found that doses of 400-1200 ,ug. 9,10-
dimethyl-1,2-benzanthracene (DMBA) effectively initiated the induction of skin
tumours when given orally, intravenously, or intraperitoneally to adult mice.
Croton oil, applied to the skin, was the promoter. Small doses of DMBA induce
malignant lymphomas, lung adenomas and a wide variety of other tumours when
injected into newborn mice (Pietra, Spencer and Shubik, 1959; Pietra, Rappaport
and Shubik, 1961; Roe, Rowson and Salaman, 1961; Toth, Rappaport and
Shubik, 1962, 1963). The present experiments were designed to see whether
DMBA injected, subcutaneously, in low doses during the neonatal period has an
initiating effect on the skin.
MATERIALS AND METHODS
Chemicals.-9,10-Dimethyl-1,2-benzanthracene (DMBA) was obtained from
Roche Products Ltd. and prepared for injection as a colloidal suspension in 3%
aqueous gelatine, using the method of Pietra et al. (1959). Gelatine powder was
obtained from British Drug Houses. Croton oil, from Messrs. Boots Pure Drug
Co., was used as a 0 1% (v/v) solution in acetone.
Mice.-Chester Beatty stock mice were used for Experiment 1, and BALB/c
(Bittner agent free) mice for Experiment 2. The line of BALB/c was originally
obtained from Dr. H. B. Andervont of the National Cancer Institute, Bethesda,
Maryland, and has been maintained in this Institute by brother-sister mating since
1952.
Mice were weaned when they were four weeks old and the sexes were separated.
Four to six mice were housed together in metal cages. They received a cubed diet
(Diet 86, Messrs. Dixon and Sons, Ware, Herts.) and tap water ad libitum. As a
precaution against ectromelia all mice were vaccinated with sheep lymph when
they were about six weeks old.
Before the start oftreatment to the skin the hair was removed from the whole
back by electric clippers. Croton oil in acetone, acetone only, or, in the case ofSKIN TUMOURS WITH DMBA AND CROTON OIL
Group 4, DMBA in acetone solution, was delivered from calibrated pipettes in such
a way that the entire clipped area was covered. The appearance, regression and
size of all skin tumours were recorded weekly. Sick mice, which were killed,
mice which died and the animals killed at the end of the experiments were all
examined thoroughly post mortem. A proportion ofthe skin tumours which arose,
and all lesions from other organs which were possibly neoplastic, were taken for
microscopic examination.
Experiment 1
Twenty-two litters wererandomly dividedinto fourgroups offortytofiftymice.
The mice in Groups 1 and 2 were injected, subcutaneously, with 45 jug. DMBA in
0*02 ml. of 3% aqueous gelatine when they were less than twenty-four hours old.
Group 3 was similarly treated with 0-02 ml. aqueous gelatine alone. At six weeks,
each mouse in Group 4 was painted with 150 #g. DMBA in 0 3 ml. acetone.
Weekly applications of 0.1% croton oil in acetone (Groups 1, 3 and 4) or acetone
alone (Group 2) were started during the eighth week. Eachmouse received 0 3 ml.
per application. Survivors were killed afterthirty paintings, i.e. during the thirty-
eighth week of the experiment.
RESULTS
Survival from the eighth week to the thirty-sixth week (two weeks before the
survivors were killed) and the accumulation ofskin tumours are shown in Table I.
No skin papillomas were seen in Group 3 (aqueous gelatine and croton oil) and only
one was recorded in Group 2 (DMBA and acetone). However, mice ofboth sexes
injected at birth with DMBA and subsequently painted with croton oil (Group 1)
developed multiple skin papillomas, although the total number of skin tumours
recorded was lowerthanthat inGroup 4 andtherewerefewertumour-bearing mice.
Group 4 was included as a positive control: the mice were treated with DMBA (by
application to the skin) as adults, then had the same croton oil treatment as
Groups 1 and 3.
The first papillomas appeared during the nineteenth week of the experiment
(i.e. after eleven applications of croton oil), both in Group 1 and in Group 4. The
incidence of skin tumours was calculated from the total of tumour-bearing/mice
and the number of survivors at the time of the appearance of the first tumour.
One tumour, from a female in Group 4 killed after thirty-eight weeks, was
found on microscopic examination to be a squamous cell carcinoma which was
invading the dermis, but had not penetrated the panniculus muscle.
Table II shows the incidence oflung tumours and other neoplasms. The pro-
portion of mice with lung adenomas was similar in Groups 1 and 2, and much
higher in these groups than in mice which were not injected with DMBA when
newly born. The mean nodule counts were low in Groups 3 and 4 and higher in
Group 1 than in Group 2. The difference in lung tumour multiplicity when the
neonatal injection of DMBA is followed by treatment with croton oil rather than
acetone is significant for females (P = 0.001) but not for males. The mean size
of the largest tumour was also greater for the females of Group 1 than for the
females of Group 2, but the difference was not significant (P = 0.1). Lung
tumours were classified by a method described by Walters (1966). Class 1
includes small well circumscribed adenomas; Class 2, tumours which have invaded
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adjacent bronchi or bronchioles; Class 3, tumours which have given rise to metas-
tases elsewhere in the lung. Class 3 tumours which were regarded as malignant,
and Class 2 tumours, were only seen in mice injected at birth with DMBA.
Pleomorphic sarcomas at the injection site were seen in one mouse in Group 1
and two mice in Group 2. Malignant lymphomas occurred in mice of all groups.
Multiple hepatomas were found in males, but not in females. The incidence in
Groups 1 and 2 was far greater than in Groups 3 and 4. Females in Groups 1 and 2
developed haemangiomas of the uterus and ovary, and there was one granulosa
cell tumour of the ovary in Group 2. One male in Group 1 and one in Group 2
had subcutaneous haemangiomas.
Experiment 2
Thirty litters were allotted randomly to six groups. At the start ofthe experi-
ment there were between forty and fifty mice in each group. The mice in Group 1
were injected subcutaneously with 0-02 ml. of 3% aqueous gelatine, less than
twenty-four hours after birth. Group 2 were similarly treated with 5 ,ug. DMBA
in aqueous gelatine; Group 3 received 15,tg. DMBA; and Groups 4 and 5 received
45 ,ug. DMBA. The mice in Group 6 were injected when they were about eight
weeks old (body weights of 18 g. ± 2 g.). On three successive days they received
two subcutaneous injections (one in each flank), of 30 ,ug. DMBA. The total
dose was 180 zg. Groups 1, 2, 3, 4 and 6 were painted once each week with 0-25
ml. of 0-1% croton oil in acetone for forty weeks. The treatment was started
during the eighth week in Groups 1-4 and during the ninth in Group 6. The
control mice in Group 5 received forty weekly applications of 0-25 ml. acetone.
The survivors in Groups 1-6 were killed about one week after the end ofthe treat-
ment with croton oil or acetone.
Group 7 was included as a positive control group to check the susceptibility of
BALB/c mice to skin carcinogenesis by DMBA and croton oil. Fifteen twelve-
week-old females received one application to the skin of 150,ug. ofDMBA in 0-2 ml.
acetone. Weekly treatments of croton oil started three weeks later. The mice
received twenty-five applications of 0-25 ml., and were killed at the end of that
time.
RESULTS
Tumour incidence in BALB/c mice after treatment with DMBA and croton oil
is shown in Table III. Only three of the fifteen mice in Group 7, painted with
150 fig. DMBA and croton oil for twenty-five weeks, developed skin papillomas.
Each mouse had only one tumour and the earliest appeared after sixteen applica-
tions of croton oil. Very few skin tumours arose in Groups 2, 3, 4 and 5. Only
one mouse, a female in Group 4, had more than one papilloma: four tumours
were recorded after twenty applications of croton oil. Papillomas appeared in
one male in Group 4 and one female in Group 5 before the croton oil treatment
began.
Twenty-two out of twenty-seven females and ten out of ten males in Group 6
developed pleomorphic or spindle cell sarcomas in one or both flanks. (A dose of
90 ,ig. DMBA was deposited at each injection site). Six of the tumours were
removed but recurred after three or four weeks. One spindle cell sarcoma was
removed successfully. Most of the tumours had invaded the skin or the muscles
of the body wall.
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One hundred per cent ofthe survivors in Groups 2, 3, 4, 5 and female survivors
in Group 6 developed lung adenomas. The mean nodule count increased between
Groups 2 and 3 and Groups 3 and 4, with the increasing dose ofneonatally injected
DMBA. Females developed more lung tumours than males, but the difference
was not significant except in Group 2 where P < 0 05. There were too few sur-
vivors in Groups 4 and 5 for comparison. Tumour multiplicity in mice ofGroup 4
injected with 45 pug. DMBA and painted with croton oil was almost the same as
that in Group 5 mice, which received the same dose ofDMBA, but acetone instead
of croton oil. Class 3 and Class 2 lung tumours arose only in mice which were
injected with DMBA at birth.
DISCUSSION
Chester Beatty Stock mice injected subcutaneously with 45 ,ug. DMBA at
birth and painted once weekly with croton oil from the eighth week developed
multiple skin papillomas. It is concluded that the DMBA acted as an initiator,
since applications of croton oil following neonatal injections of aqueous gelatine
induced no skin tumours. Applications of croton oil as well as DMBA injections
were necessary for the development ofskin papillomas: only one tumour was seen
in the group injected with DMBA but painted with acetone. Thus, two factors
were involved in skin carcinogenesis. Neonatally injected DMBA was the initiator
and croton oil, applied to the skin, the promoter.
The initiating activity of 45 ,ug. DMBA injected into newborn mice was weaker
than that of 150 pg. applied to the skin of adults. Tumour incidence was 53.300
in females and 4000 in males treated whennewly born: 91.3% in females and 82.4%
in males treated at six weeks. The difference may be due to the dose of DMBA
which actually reaches the skin being higher when it is applied directly to the skin
ofthe adult. The interval before the appearance ofthe first papilloma was similar
in both groups. Most skin tumours were benign, but one squamous cell carcinoma
was seen in a mouse killed during the thirty-eighth week, which received one
application to the skin of DMBA followed by thirty applications of croton oil.
Malignant skin tumours, defined as those which had invaded the panniculus
carnosus muscle, arose in long-term experiments in which mice were painted with
DMBA and croton oil (Roe, 1956), and probably would have arisen in larger num-
bers in the present experiment ifthe animals had been observed for a longer period.
Mice given urethane (1 mg./g. body weight) when newly born followed by
croton oil developed skin papillomas with an incidence significantly higher (4400)
than mice given an equivalent dose of urethane subcutaneously at forty days and
similar treatment with croton oil (19.5%). The mean latent period was practically
the same. It was thought likely that different amounts of urethane reached the
skin in mice treated at different times. Chieco-Bianchi and his colleagues (1963)
believed that their results, which showed that groups receiving the same croton oil
treatment had different tumour yields but almost the same latency, were consis-
tent with the original hypothesis of Berenblum and Shubik (1947). On the basis
of a two-stage theory of skin carcinogenesis, tumour incidence is a function of
initiating action, while the latent period is a function of promoting action.
Skin tumour incidence in the " positive " control group of BALB/c mice.
which received a single application of IDMBA to the skin followed by twenty-five
applications of croton oil, was very low. BALB/c mice therefore appear to be
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relatively insensitive to skin tumour induction by DMBA and croton oil: " 101 "
strain mice painted with 150 ,tg. DMBA developed multiple papillomas after six-
teen weeks of croton oil treatment (Roe and Peirce, 1961). The fact that few
tumours arose in mice injected subcutaneously with DMBA whennewly born, or as
adults, may also be only an indication of the insensitivity of the strain, since a
positive result was obtained using stock mice.
The mean number of lung tumours per mouse was significantly higher (P
0.001) in female stock mice injected at birth with DMBA and subsequently painted
with croton oil, than in females which were treated with DMBA and acetone only.
In male stock mice, however, and in BALB/c mice of both sexes, the difference
was not significant. It is therefore doubtful whether croton oil can have a
promoting effect on lung tumour induction.
Hepatomas, which occurred in a high proportion of male stock mice injected
neonatally with DMBA, have rarely been induced by polycyclic hydrocarbons in
adult animals. The induction of liver tumours by injecting polycyclic hydro-
carbons into newborn mice has been discussed by Roe and Walters (1966).
The results reported here once again indicate that precautions should be
taken in experiments in carcinogenesis to prevent the exposure of young animals
to carcinogenic contaminants. Such contamination may both increase the
incidence of so-called " spontaneous " tumours and initiate tumour formation in
tissues such as the skin (Boutwell and Bosch, 1958; Roe, Bosch and Boutwell,
1958). If adventitious initiation occurs in this way tumour promoters may be
mistaken for carcinogens.
SUMMARY
Chester Beatty Stock mice of both sexes, injected at birth with 45 ,tg. DMBA
in aqueous gelatine and treated from the age ofsix weeks with weekly applications
to the skin of 0-1% croton oil in acetone for thirty weeks, developed multiple skin
papillomas. The carcinogenic response was lower than in a group ofmice treated
with a single application to the skin of 150 ,ug. DMBA in acetone at six weeks
followed by thirty applications of croton oil at weekly intervals. No skin papil-
lomaswere seen inmiceinjectedneonatallywith aqueous gelatine andsubsequently
painted with croton oil. Only one skin tumour was recorded in a group injected
at birth with DMBA and treated with thirty weekly applications of acetone. It
was concluded that neonatally-injected DMBA has initiating activity for the skin,
but it is less potent than a direct application to the skin of a six-week-old mouse.
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